BioDtech, Inc. (BDTI) an emerging life science company, today announced that it will relocate its corporate headquarters from Nashville, Tennessee to Birmingham, Alabama. The company plans to expand its existing R&D efforts in the new Innovation Depot facility located in the Entrepreneurial District in downtown Birmingham near the University of Alabama Birmingham (UAB).
“We are making this move to take advantage of an area that combines a strong intellectual talent pool with a world class research facility so that we can continue to execute our plan to profitability, while building our company for the future,” commented Michael Pepe, President and CEO of BDTI.
The company anticipates relocation of its headquarters to be complete by July 2007. BDTI will continue to operate production and distribution from its existing Nashville facility located in the Nashville Business Incubation Center (NBIC) located at Tennessee State University.
BioDtech, Inc. will be presenting its strategic plans at the 9th C21 BioVentures conference in Monterey, California from May 22-24, 2007.
BioDtech, Inc. was founded in 2003 to accelerate the development of technologically advanced products geared toward the endotoxin market. BDTI’s current product line gives researchers the necessary reagents to detect, neutralize and remove endotoxin from their test samples. In the future BDTI anticipates that its technology will change the way biological toxins are monitored and handled. To learn more about BDTI, visit http://www.biodtechinc.com.
BDTI is a registered trademark of BioDtech, Inc. in the United States and other countries. All other marks are the property of their respective owners.